{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"EyePoint Pharmaceuticals, Inc."},"Symbol":{"label":"Symbol","value":"EYPT"},"Address":{"label":"Address","value":"480 PLEASANT STREET,SUITE B300, WATERTOWN, Massachusetts, 02472, United States"},"Phone":{"label":"Phone","value":"+1 617 926-5000"},"Industry":{"label":"Industry","value":"Biotechnology: Laboratory Analytical Instruments"},"Sector":{"label":"Sector","value":"Industrials"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert and Verisome Technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases."},"CompanyUrl":{"label":"Company Url","value":"https://www.eyepointpharma.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Jay S. Duker","title":"President, Chief Executive Officer & Director"},{"name":"Jennifer Leonard","title":"Chief People Officer & Senior Vice President-IT"},{"name":"Michael J. Maciocio","title":"Senior VP-Manufacturing & Operations"},{"name":"Ramiro Ribeiro","title":"Chief Medical Officer"},{"name":"Said Saim","title":"Chief Technology Officer & Senior VP"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}